<?xml version="1.0"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel><title>WRALLocalTechWire.com - Biotech</title><link>http://www.wral.com/business/local_tech_wire/biotech/</link><description>WRALLocalTechWire.com - Biotech</description><copyright>Copyright 2008 by WRAL.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.</copyright><pubDate>Fri, 10 Oct 2008 13:46:30 -0400</pubDate><lastBuildDate>Fri, 10 Oct 2008 13:46:30 -0400</lastBuildDate><ttl>60</ttl><item><title>UNC Chapel Hill, Emory receive CDC funding to launch public health preparedness centers</title><link>http://www.wral.com/business/local_tech_wire/biotech/story/3706816/</link><description>&lt;img src="http://wwwcache.wral.com/asset/business/local_tech_wire/biotech/2008/10/09/3706849/CDC-160x120.jpg" alt="CDC" /&gt;Seven centers will focus on emergency response capabilities. </description><media:thumbnail url="http://wwwcache.wral.com/asset/business/local_tech_wire/biotech/2008/10/09/3706849/CDC-160x120.jpg" alt="CDC" height="120" width="160"></media:thumbnail><pubDate>Thu, 09 Oct 2008 15:00:06 -0400</pubDate><category></category><guid isPermaLink="true">http://www.wral.com/business/local_tech_wire/biotech/story/3706816/</guid></item><item><title>Inspire Pharmaceuticals launches clinical trial for glaucoma treatment</title><link>http://www.wral.com/business/local_tech_wire/biotech/story/3713413/</link><description>{{a href=&amp;quot;external_link-0&amp;quot;}}Inspire Pharmaceuticals{{/a}} (Nasdaq: ISPH) has launched a Phase I clinical trial of a potential new drug to combat glaucoma.</description><pubDate>Fri, 10 Oct 2008 13:46:08 -0400</pubDate><category></category><guid isPermaLink="true">http://www.wral.com/business/local_tech_wire/biotech/story/3713413/</guid></item><item><title>FDA warns LabCorp about sale of new ovarian cancer screening test</title><link>http://www.wral.com/business/local_tech_wire/biotech/story/3706490/</link><description>Laboratory Corporation of America (NYSE: LH) has received a {{a href=&amp;quot;external_link-3706494&amp;quot;}}warning letter from the U.S. Food and Drug Administration{{/a}} about its recently launched ovarian cancer screening test.</description><pubDate>Thu, 09 Oct 2008 15:21:42 -0400</pubDate><category></category><guid isPermaLink="true">http://www.wral.com/business/local_tech_wire/biotech/story/3706490/</guid></item></channel></rss>
